Search for: "Glaxo Wellcome Inc. v. United States"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
6 Mar 2014, 12:41 pm
Glaxo Wellcome PLC, 246 F.3d 934 (7th Cir. 2001). [read post]
27 Aug 2018, 3:11 pm
A happy outcome in the United States was the decision here in Christian Louboutin S.A. v Yves Saint Laurent America Inc., No. 11-3303 (2d Cir. 2012) 1 ‘…the Red Sole Mark has acquired limited secondary meaning as a distinctive symbol that identifies the Louboutin brand, and…it is therefore a valid and protectable mark…’ (page 25) here.A second problem featured in the recent decision of the Court of Justice of the… [read post]
24 May 2007, 10:40 am
Trailmaster Products, Inc., 625 A.2d 1005, 1014 (Md. 1993); Dentson v. [read post]
2 Jun 2011, 12:46 pm
State, 686 S.E.2d 483, 485-86 (Ga. [read post]
5 Jul 2007, 10:37 am
Glaxo, Inc., 790 So.2d 35, 38 (La. [read post]
26 Jun 2007, 7:00 am
In Washington State Physicians Insurance v. [read post]
26 Feb 2011, 3:47 pm
Festo, 493 F.3d at 1379 n.8 (citing Glaxo Wellcome, Inc. v. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
28 Apr 2011, 3:18 pm
At least the state of the art at the time of the plaintiff’s use applies – unknown and later discovered risks are irrelevant. [read post]
